SEP 13, 2015 10:49 AM PDT

Melatonin Matters for MS

WRITTEN BY: Ilene Schneider
Symptoms of multiple sclerosis (MS) seem to get better in the winter and worse in the summer, so a group led by Francisco Quintana at the Ann Romney Center for Neurologic Diseases at Brigham and Women’s Hospital (BWH) sought an explanation.
Melatonin may influence multiple sclerosis activity. 
The researchers think they have found one that could lead to a deeper understanding of the disease and more targeted treatment options for patients. By looking at possible environmental factors and then at preclinical models of MS, the research team found that melatonin, a hormone involved in regulating a person’s sleep-wake cycle, may influence MS disease activity. The team reported its findings in Cell, and the work was covered in the Harvard Gazette and Bioscience Technology
 
While the work does not mean that MS patients should start taking supplements of melatonin, the new approach can be viewed as a first step toward better and more targeted therapies, the researchers said. According to co-corresponding author Quintana, associate professor in the Ann Romney Center and at Harvard Medical School, “We know that for multiple sclerosis and most autoimmune diseases, both genetic and environmental factors play an important role, but in the last decade or so, most research has focused only on the genetic side of the equation. But we wanted to see what environmental factors would reveal to us about this disease. We knew that MS disease activity changed with the seasons. What we’ve uncovered offers an explanation for why that is the case.”
 
Working with the Center for Research on Neuroimmunological Diseases (CIEN) at the Raul Carrea Institute for Neurological Research (FLENI) in Argentina, Quintana’s team started by studying patients. During the fall and winter, the group of 139 relapsing remitting MS patients experienced a significant improvement in symptoms, a phenomenon observed in prior studies. The team explored a variety of environmental factors potentially linked to MS symptoms, including vitamin D levels, UV incidence and upper respiratory tract infections, but the factor consistently associated with severity of MS symptoms was melatonin. During the longer days of the spring and summer, melatonin levels are lower; during the shorter days of the fall and winter, levels are higher.
 
Based on this finding, the team studied the role that melatonin may play on a cellular level. With a mouse model and human cells, they determined the effects of melatonin on certain types of cells that affect the immune response that leads to MS symptoms. The team discovered that melatonin affected the roles of two kinds of cells that are important in MS disease progression: pathogenic T cells, which directly attack and destroy tissue, and regulatory T cells, which are supposed to keep pathogenic T cells in check.
 
According to Quintana, “We found that melatonin has a protective effect. It dampens the immune response and helps keep the bad guys — or pathogenic T cells — at bay.  In the future, melatonin or its derivatives may be used in MS patients after appropriate clinical trials are conducted and dosage is established. However, extreme caution should be exercised: Our data do not show that melatonin or its analogs are effective in treating MS.”
About the Author
Ilene Schneider is the owner of Schneider the Writer, a firm that provides communications for health care, high technology and service enterprises. Her specialties include public relations, media relations, advertising, journalistic writing, editing, grant writing and corporate creativity consulting services. Prior to starting her own business in 1985, Ilene was editor of the Cleveland edition of TV Guide, associate editor of School Product News (Penton Publishing) and senior public relations representative at Beckman Instruments, Inc. She was profiled in a book, How to Open and Operate a Home-Based Writing Business and listed in Who's Who of American Women, Who's Who in Advertising and Who's Who in Media and Communications. She was the recipient of the Women in Communications, Inc. Clarion Award in advertising. A graduate of the University of Pennsylvania, Ilene and her family have lived in Irvine, California, since 1978.
You May Also Like
JUL 23, 2022
Health & Medicine
Detecting Covert Consciousness with EEG and Artificial Intelligence
JUL 23, 2022
Detecting Covert Consciousness with EEG and Artificial Intelligence
For those who appear totally unresponsive, researchers have discovered that signs of covert consciousness or subtle brai ...
AUG 01, 2022
Cell & Molecular Biology
Representation in STEM Matters
AUG 01, 2022
Representation in STEM Matters
Amid the increasing conversation regarding diversity and inclusion, it is important to understand the role they both pla ...
AUG 04, 2022
Clinical & Molecular DX
Artificial Intelligence Shows Promise in Diagnosing Strokes
AUG 04, 2022
Artificial Intelligence Shows Promise in Diagnosing Strokes
Quick identification and intervention is critical in successfully treating a stroke. During a stroke, blood supply to th ...
SEP 01, 2022
Technology
Fingertip Sensor to Measure Lithium Levels in Bipolar Patients
SEP 01, 2022
Fingertip Sensor to Measure Lithium Levels in Bipolar Patients
Lithium is a common treatment for certain mental health conditions, including bipolar disorder and depression. In fact, ...
SEP 13, 2022
Clinical & Molecular DX
Stress During Pregnancy Linked to Negative Emotions in Infants
SEP 13, 2022
Stress During Pregnancy Linked to Negative Emotions in Infants
Stress during pregnancy can have long lasting effects and can impact emotional and physical development in children. Pas ...
SEP 27, 2022
Clinical & Molecular DX
New Research Elucidates the Mechanism of Skin Cancer Metastasis to the Brain and Points to Groundbreaking Treatment
SEP 27, 2022
New Research Elucidates the Mechanism of Skin Cancer Metastasis to the Brain and Points to Groundbreaking Treatment
In advanced stages of skin cancer, patients develop brain metastases about 90% of the time. Though this is one of the mo ...
Loading Comments...